Trial intelligence / Profile preview

Tranexamic acid (Cyklokapron) in surgery for advanced ovarian cancer

2006-006714-14Phase 4Completed

Sponsor
Kvinnokliniken i Östergötland
Start
Nov 2007
Modality
Small Molecules
Countries
1
01

Overview

Phase 4, randomised, double-blind trial in ovarian cancer comparing Tranexamic acid (Cyklokapron) with Placebo (2 arms). Primary endpoint: Perioperative blood loss. Started Nov 2007; status: completed.

02

Drugs

tranexamic acid
03

Conditions

ovarian cancer

Beyond the preview

Go deeper on 2006-006714-14.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2006-006714-14.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call